Nachrichten zur Kimberly-Clark Corp. Aktie

The Multibillion-Dollar Battle For Metsera’s Obesity Drugs

In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator,…

Tylenol maker Kenvue secures deal from consumer goods giant

Kimberly-Clark, manufacturer of consumer goods and personal care products, is best known for its paper-based products, including Scott, Cottonelle, Kleenex,…

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand resilient

Kimberly-Clark CEO Mike Hsu discussed his companys $48.7 billion acquisition of Kenvue in a Monday interview with CNBCs Jim Cramer.…

Factbox-Kenvue’s legal risks loom over planned acquisition by Kimberly-Clark By Reuters

Factbox-Kenvue’s legal risks loom over planned acquisition by Kimberly-Clark…

Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith By Reuters

Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith…

Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith

Kimberly-Clarks nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the worlds biggest consumer market, the…

Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.…

Why Kimberly-Clark (KMB) Stock Is Nosediving

Shares of household products company Kimberly-Clark (NYSE:KMB) fell 12.6% in the afternoon session after it announced a deal to acquire…

Kimberly-Clark buys out Kenvue in $48.7B consumer health merger

Kimberly-Clark has placed an ambitious bet on a troubled counterpart,…

S&P 500, Nasdaq gain after Amazon-OpenAI deal; Kenvue soars after buyout

The S&P 500 and Nasdaq kicked off November on firmer ground on Monday, after a slew of AI deals boosted…

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

Caroline Woods: Big brands and big money - Kimberly-Clark is buying Kenvue in a nearly $50 billion cash and stock…

Huggies maker Kimberly-Clark is buying Tylenol maker Kenvue

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the…

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.…

Kimberly-Clark, Starbucks Push Deal Boom Toward $4 Trillion

Dealmakers inked mergers and acquisitions worth more than $80 billion on Monday as they hurtle toward their second best year…

Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.…

Tylenol’s parent company will combine with the maker of Huggies in a $48.7 billion mega-deal

Huggies’ maker Kimberly-Clark announced Monday it’s buying Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a consumer…

Kimberly-Clark to acquire Kenvue in $48.7 billion deal

Kimberly-Clark said on Monday it will acquire Tylenol maker Kenvue in a deal valued at about $48.7 billion.…

Kimberly-Clark to acquire Tylenol-maker Kenvue in $48.7B deal

Kimberly-Clark Corp (NYSE:KMB, ETR:KMY) announced it will acquire Kenvue (NYSE:KVUE), the maker of Tylenol and other consumer health products, in…

Kimberly-Clark beats quarterly sales estimates as demand holds for household staples

Huggies diaper maker Kimberly-Clark topped analysts estimates for third-quarter sales on Thursday, as inflation-weary consumers gravitated toward its affordable staples.…

Kimberly-Clark Stock Shows Its Strength as Defensive Names Come Back in Focus

Key PointsInitiated position: 79,790 shares added, estimated at approximately $9.92 million as of Q3 2025The position accounts for 1.55% of…

Kimberly-Clark stock hits 52-week low at 124.09 USD By Investing.com

Kimberly-Clark stock hits 52-week low at 124.09 USD…

Kimberly-Clark: Portfolio Realignment Supports Upside Case

…

Kimberly-Clarks Q2 Earnings Top Estimates, 2025 Outlook Raised

KMB beats second-quarter estimates despite sales dip, driven by five-year high volume growth, and raises 2025 outlook.…

Kleenex tissue maker Kimberly-Clarks quarterly sales jump on strong demand

Kimberly-Clark on Friday posted a rise in second-quarter organic sales and beat profit estimates, led by steady demand for products…

Kimberly-Clark (KMB) Expected to Beat Earnings Estimates: Should You Buy?

Kimberly-Clark (KMB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

3 High-Yielding Stocks That Investors Can Buy and Forget About

Key PointsThe stocks listed here pay more than 3% in dividends.Their payout ratios are sustainable, and these businesses have strong…

Why Are These 3 High-Yield Dividend King Stocks Near 52-Week Lows While the S&P 500 Just Hit an All-Time High?

The S&P 500 (SNPINDEX: ^GSPC) closed out the first half of the year at an all-time high -- a remarkable…

Kimberly-Clark: Powering Care And Suzano Partnership Essential For Reviving Margins

…

Suzano’s rating outlook revised to positive by S&P after Kimberly-Clark deal By Investing.com

Suzano’s rating outlook revised to positive by S&P after Kimberly-Clark deal…

Suzano und Kimberly-Clark geben Gründung eines globalen Tissue-Unternehmens bekannt, das in über 70 Ländern tätig sein wird

SÃO PAULO--(BUSINESS WIRE)--Suzano, der weltweit größte Zellstoffhersteller, und Kimberly-Clark, ein weltweit führendes Unternehmen der Konsumgüterindustrie, gaben heute die Gründung eines…

Suzano stock soars on joint venture news; Kimberly-Clark dips By Investing.com

Suzano stock soars on joint venture news; Kimberly-Clark dips…

Kimberly-Clark to sell international tissue business in $3.4 billion deal

Kimberly-Clark will sell its international tissue business in a deal valued at about $3.4 billion, including debt, to Brazilian pulp…

Kimberly-Clark nears sale of Kleenex division outside North America for $3.5 billion

Kimberly-Clark nears sale of Kleenex division outside North America for $3.5 billion - report…

Kimberly-Clark Sells Global Tissue Unit in $3.4 Billion Deal

Kimberly-Clark Corp. has agreed to sell a majority stake in its global Kleenex and tissue businesses outside of North America…

Should Passive Income Investors Buy Kimberly-Clark Stock?

Kimberly-Clark (NYSE: KMB) said tariffs would negatively impact the companys profits by hundreds of millions of dollars. *Stock prices used were…

Kimberly-Clark (KMB) Up 5.8% Since Last Earnings Report: Can It Continue?

Kimberly-Clark (KMB) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Kimberly-Clark investing $2B outside Wisconsin, sparking concerns

Kimberly-Clark announces major investment in Ohio & South Carolina, but in Wisconsin, where it was founded more than 150 years…

Kimberly-Clark announces plans to invest over $2 Billion to Expand US Manufacturing, Accelerate Innovation and Fuel Growth

/PRNewswire/ -- Kimberly-Clark Corporation (NYSE: KMB) today announced plans to invest over $2 billion over the next 5 years in…

Tariff Troubles Are No Match for This Dividend Kings Rock-Solid High-Yield Payout

Earnings seasons are excellent opportunities to get updates on where companies are and where they could be headed. This earnings…

Why Kimberly-Clark Stock Was Swooning on Tuesday

An unwelcome change in guidance was the development pushing down Kimberly-Clarks (NYSE: KMB) share price on Tuesday. The sturdy consumer goods…

Kimberly-Clarks Q1 Earnings Top Estimates, Organic Sales Down 1.6%

KMBs first quarter sales dip 6%, with organic sales declining 1.6%. Management updates 2025 outlook amid cost pressures and global…

Kimberly-Clark cuts annual profit forecast as tariffs set to drive up costs

Kimberly-Clark slashed its annual profit forecast on Tuesday as the Kleenex tissue maker warned that U.S. President Donald Trumps broad-based…

Analysts Estimate Kimberly-Clark (KMB) to Report a Decline in Earnings: What to Look Out for

Kimberly-Clark (KMB) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

3 High-Yielding Dividend Stocks That Retirees Can Buy and Forget About

"Buy and hold" is a simple strategy for investors, but it can be a hard one to stick to in…

Kimberly-Clark: Streamlining Portfolio & Global Footprint; Initiate With Buy

…

Kimberly-Clark Up 7% in a Month: Is the Stock Still a Good Buy?

KMB focuses on growth through innovation, premium products and global expansion, despite challenges from currency volatility and softening demand.…

3 Dividend Stocks to Double Up on Right Now

Dividends are one of the best sources of passive income you can receive. The good news is that numerous stocks…

Kimberly-Clark names new VP and Controller By Investing.com

Kimberly-Clark names new VP and Controller…

Kimberly-Clark: Sales Beat, EPS Miss

Kimberly-Clark reported mixed earnings, with revenue surpassing estimates but EPS slightly missing the mark.…

Kimberly-Clark forecasts strong annual profit growth

Kimberly-Clark forecast annual adjusted profit growth ahead of Wall Street estimates and reported better-than-expected quarterly sales on Tuesday as the…